CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases

CD30 expression is the hallmark of the cutaneous CD30+ lymphoproliferative disorders, lymphomatoid papulosis and anaplastic large cell lymphoma. We report CD30 expression in cutaneous follicle center cell lymphoma and in cutaneous post-transplant peripheral T-cell lymphoma. Histopathologists should...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatology online journal Jg. 20; H. 7
Hauptverfasser: Albrecht, Hana, Woodroof, Janet M, Reyes, Ruben, Powers, Benjamin C, Fraga, Garth R
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States University of California Digital Library - eScholarship 2014
Schlagworte:
Aged
B-Lymphocytes - immunology
B-Lymphocytes - metabolism
B-Lymphocytes - pathology
Biopsy
Female
Follow-Up Studies
Humans
Immunohistochemistry
Ki-1 Antigen - biosynthesis
Ki-1 Antigen - immunology
Lymphoma, T-Cell, Peripheral - immunology
Lymphoma, T-Cell, Peripheral - metabolism
Lymphoma, T-Cell, Peripheral - pathology
Middle Aged
Prognosis
Skin - immunology
Skin - pathology
Skin Neoplasms - immunology
Skin Neoplasms - metabolism
Skin Neoplasms - pathology
ISSN:1087-2108, 1087-2108
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:CD30 expression is the hallmark of the cutaneous CD30+ lymphoproliferative disorders, lymphomatoid papulosis and anaplastic large cell lymphoma. We report CD30 expression in cutaneous follicle center cell lymphoma and in cutaneous post-transplant peripheral T-cell lymphoma. Histopathologists should be aware of CD30 expression in cutaneous lymphomas outside the realm of so-called CD30+ lymphoproliferative disorders to avoid diagnostic errors and improper medical treatment.
Bibliographie:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Report-1
ObjectType-Feature-4
content type line 23
ObjectType-Article-3
ISSN:1087-2108
1087-2108
DOI:10.5070/D3207023132